ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
97,340.90
-0.44%
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs Yen
156.445
-0.01%
Brent Oil
72.72
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Assertio Holdings Inc (ASRT) 銘柄情報

Assertio Holdings Inc

Assertio Holdings Inc (ASRT)

BNP Paribas Asset Management Luxembourg
0.8859
0.0429
(5.09%)
終了 12月22日 6:00AM
15分遅延
0.9084
0.0225
(2.54%)
取引時間後: 8:14AM
15分遅延

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
0.9084
買値
0.90
売値
0.9084
出来高
748,639
0.818 日の範囲 0.9091
0.7324 52 週間の範囲 1.798
時価総額
86.732M
前日終値
0.843
始値
0.818
時刻
1
@
0.9
最終取引時間
財務取引量
US$ 658,763
VWAP
0.879948
平均取引量 (3 か月)
765,192
発行済株式数
95,477,800
配当利回り
-
PER
-0.26
1 株当たり利益 (EPS)
-3.48
歳入
152.07M
純利益
-331.94M

Assertio Holdings Inc について

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management... Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.assertiotx.com
本社
Wilmington, Delaware, USA
設立
-
Assertio Holdings Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ASRT. The last closing price for Assertio was US$0.84. Over the last year, Assertio shares have traded in a share price range of US$ 0.7324 to US$ 1.798.

Assertio currently has 95,477,800 shares in issue. The market capitalisation of Assertio is US$80.49 million. Assertio has a price to earnings ratio (PE ratio) of -0.26.

ASRT 最新ニュース

その他のニュース

Form 8-K - Current report

2024年12月18日
Edgar (US Regulatory)

Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors

LAKE FOREST, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...

2024年12月17日
GlobeNewswire Inc.

Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study

LAKE FOREST, Ill., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...

2024年12月13日
GlobeNewswire Inc.

Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO

LAKE FOREST, Ill., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...

2024年12月12日
GlobeNewswire Inc.

Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer

CAMBRIDGE, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced...

2024年12月6日
GlobeNewswire Inc.

Form 8-K - Current report

2024年11月12日
Edgar (US Regulatory)

Assertio Reports Third Quarter 2024 Financial Results

Third Quarter Total Net Product Sales of $28.7 Million Rolvedon Net Product Sales of $15.0 Million  Cash and Short-Term Investments of $88.6 Million LAKE FOREST, Ill., Nov. 11, 2024 (GLOBE...

2024年11月12日
GlobeNewswire Inc.

Assertio Provides Response to Letter from Short-seller

Claims about Rolvedon and Assertio’s Accounting Practices are False and Baseless Short-seller’s Press Release is Another Improper Attempt to Enrich Himself at Assertio’s Expense Company...

2024年11月11日
GlobeNewswire Inc.

Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024

LAKE FOREST, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...

2024年10月30日
GlobeNewswire Inc.

Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024

LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...

2024年10月11日
GlobeNewswire Inc.
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.0521-5.424258198850.96050.98160.82210156750.88816793CS
4-0.0379-4.005072387190.94631.07910.8229303510.94649479CS
12-0.2916-24.31.21.2480.787651920.96557521CS
26-0.1916-17.41818181821.11.7980.788255651.18564769CS
52-0.1616-15.10280373831.071.7980.73248897111.06949361CS
156-0.9316-50.63043478261.848.010.732412707073.2335641CS
260-0.2516-21.68965517241.168.010.3322458651.6804847CS

ASRT - Frequently Asked Questions (FAQ)

What is the current Assertio share price?
The current share price of Assertio is US$ 0.9084
How many Assertio shares are in issue?
Assertio has 95,477,800 shares in issue
What is the market cap of Assertio?
The market capitalisation of Assertio is USD 80.49M
What is the 1 year trading range for Assertio share price?
Assertio has traded in the range of US$ 0.7324 to US$ 1.798 during the past year
What is the PE ratio of Assertio?
The price to earnings ratio of Assertio is -0.26
What is the cash to sales ratio of Assertio?
The cash to sales ratio of Assertio is 0.56
What is the reporting currency for Assertio?
Assertio reports financial results in USD
What is the latest annual turnover for Assertio?
The latest annual turnover of Assertio is USD 152.07M
What is the latest annual profit for Assertio?
The latest annual profit of Assertio is USD -331.94M
What is the registered address of Assertio?
The registered address for Assertio is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Assertio website address?
The website address for Assertio is www.assertiotx.com
Which industry sector does Assertio operate in?
Assertio operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

ASRT Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
ASRT
Assertio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有